Image

Italian Validation of a Tool for Assessing Sexual Function After Breast Cancer, FSFI-BC

Italian Validation of a Tool for Assessing Sexual Function After Breast Cancer, FSFI-BC

Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

This is a validation study of the italian language for the Female Sexual Function Index-Breast Cancer questionnaire.

The validation of the instrument in Italian will allow the identification of possible issues related to sexual health and enable the provision of adequate medical and psychosexual counseling to these patients, both in clinical practice and in research studies.

Description

The original version of the questionnaire will be validated in two phases: a) translation, b) reliability.

  1. Translation of the items and administration to a small sample of volunteers to assess usability.

In the first phase, the questionnaire will be translated following the 5 steps:

  1. forward translation by two independent translators (from English to Italian);
  2. synthesis (discussion between translators to resolve any discrepancies);
  3. backward translation (from Italian to English) by two additional independent translators;
  4. expert committee (translators, psychologists, sexology consultants) comparing the two versions of the questionnaire; 5) testing the first version of the questionnaire with a sample (N=20) of native Italian speakers to evaluate the adequacy of content and clarity of terms used and proceeding to the final version.
  5. Reliability of the questionnaire. To assess the reliability of the questionnaire, it will be administered again after a 2-week interval to a smaller sample compared to the recruited patient sample.

Eligibility

Inclusion Criteria:

  1. Women with operable breast cancer;
  2. Operated on between 2012 and 2020;
  3. Randomly selected from the institutional database; 18 years of age (Age stratification: equally represented women aged <50 years and women aged ≥50 years);
  4. Signing of the informed consent.

Exclusion Criteria:

  1. Severe psychiatric or cognitive illness;
  2. Ongoing psychological treatment.

Study details
    Breast Cancer

NCT06340386

European Institute of Oncology

14 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.